Navigation Links
Control of inflammation

Particular cell surface molecules sense runaway inflammation and tissue damage, say researchers, Michail Sitkovsky, and his coworkers at the National Institute of Allergy and infectious Diseases (NIAID).The finding appeared in Nature.// Inflammation, tissue swelling is accompanied by pain and heat, is the body’s response to a host of insults: invasion by bacteria or viruses, injury, or reactions to one’s own tissues.

Chronic inflammation is characteristic of such disorders as asthma, chronic hepatitis, lupus and rheumatoid arthritis. Little is known about the body,s own mechanism for controlling inflammation and the tissue damage that accompanies it. According to Dr.Sitkovsky, there must be some way for the body to shout. The signal must be sensed and responded to so that inflammatory activity abates. Adenosine and its membrane-bund receptor made attractive cnadidates for signal and sensor, Sitkovsky notes.

A simple molecule that leads a busy life, adenosine is the core of the cell’s energy-containing compound, ATP, and elevated levels of it in the brain appear to cause sleep. Despite its numerous roles adenosine has received little attention from immunologists, says Sitkovsky. This much is known: when tissue damage mounts due to prolonged inflammation oxygen levels in the damaged area fall. This leads to increased amounts of adenosine outside cells. Dr. Sitkovsky theorised that the excess adenosine binds to the adenosine receptors, which then initiate a chain reaction that slows and eventually stops inflammation.

'"/>




Page: 1

Related medicine news :

1. FDA Approves Birth Control Skin Patch
2. New Birth Control Pills increase the stroke risk
3. Control of anger disorder connected to Brain Dysfunction
4. WHO Declares Vietnam First Country to Control SARS
5. The Importance Of “ Good ”Control Of Diabetes During Pregnanc
6. Controlling Asthma during Pregnancy
7. Effective Control Of Blood Sugar Levels
8. Controlling Allergies Before They Start
9. Diabetics Can Now Be Able To Control Both Blood Sugar And Their Weight
10. Better Control Of Sugar Levels
11. Controlling Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: